Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Alcon Inc (ALC)

Alcon Inc (ALC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 39,474,316
  • Shares Outstanding, K 493,244
  • Annual Sales, $ 9,911 M
  • Annual Income, $ 1,018 M
  • EBIT $ 1,442 M
  • EBITDA $ 2,668 M
  • 60-Month Beta 0.96
  • Price/Sales 3.94
  • Price/Cash Flow 14.25
  • Price/Book 1.77

Options Overview Details

View History
  • Implied Volatility 23.18% (+0.41%)
  • Historical Volatility 23.53%
  • IV Percentile 24%
  • IV Rank 17.64%
  • IV High 46.17% on 04/07/25
  • IV Low 18.26% on 01/22/25
  • Expected Move (DTE 14) 2.59 (3.28%)
  • Put/Call Vol Ratio 0.59
  • Today's Volume 118
  • Volume Avg (30-Day) 2,317
  • Put/Call OI Ratio 1.36
  • Today's Open Interest 17,748
  • Open Int (30-Day) 34,602
  • Expected Range 76.40 to 81.58

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 21 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 0.81
  • Number of Estimates 4
  • High Estimate 0.89
  • Low Estimate 0.77
  • Prior Year 0.72
  • Growth Rate Est. (year over year) +12.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
72.09 +9.57%
on 11/07/25
81.89 -3.54%
on 11/12/25
+4.80 (+6.47%)
since 11/04/25
3-Month
71.55 +10.40%
on 10/10/25
81.89 -3.54%
on 11/12/25
+0.08 (+0.10%)
since 09/04/25
52-Week
71.55 +10.40%
on 10/10/25
99.20 -20.37%
on 05/02/25
-8.85 (-10.08%)
since 12/04/24

Most Recent Stories

More News
Broadwood Partners Working to Call Special Meeting of STAAR Surgical Shareholders to Remove Three Directors

Pursuing Board Changes to Restore Investor Confidence and Ensure Integrity of Ongoing Sale Process Broadwood Seeks to Remove the Directors Most Responsible...

STAA : 26.60 (+0.87%)
ALC : 78.99 (-1.30%)
Alcon Delivers Solid Third-Quarter 2025 Results with Accelerated Growth in Equipment and Ocular Health; Unity VCS Momentum Builds

Third-quarter 2025 sales of $2.6 billion, up 6% on a reported basis, or up 5% constant currency 1 (cc), versus third-quarter 2024 ...

ALC : 78.99 (-1.30%)
Broadwood Partners Calls for the Appointment of New Directors at STAAR Surgical to Oversee Go-Shop Process

Believes New, Independent, and Experienced Directors Are Needed in Order to Restore Trust in the Board and Confidence in the Go-Shop Process Notes Recently...

STAA : 26.60 (+0.87%)
ALC : 78.99 (-1.30%)
CPI Due in U.S. Next Week

Monday (NOTE: Some economic figures from the States may be delayed this week due to the U.S. government ...

AMAT : 269.44 (+0.30%)
SONY : 28.29 (-0.60%)
CSCO : 77.76 (+0.01%)
NU : 17.65 (+1.20%)
RKLB : 49.37 (+10.40%)
ASTS : 72.65 (+18.25%)
DIS : 105.47 (-0.26%)
NTES : 139.74 (-0.84%)
OXY : 42.67 (+0.52%)
SE : 135.41 (+0.27%)
AU : 83.38 (-0.20%)
UI : 568.48 (+0.85%)
Broadwood Partners Condemns Alcon’s Fallacious Attacks on STAAR Surgical and Its Prospects

Reminds STAAR’s Board That It Does Not Need Alcon’s Permission to Remain Independent or Run a Proper Strategic Alternatives Process

STAA : 26.60 (+0.87%)
ALC : 78.99 (-1.30%)
Alcon Releases Investor Discussion Materials Reinforcing Certain Value of Merger Proposal for STAAR Stockholders

Alcon (SIX/NYSE: ALC), the global leader in eye care, today announced that it has filed an investor presentation in support of the proposed acquisition of STAAR Surgical Company (NASDAQ: STAA) with the...

STAA : 26.60 (+0.87%)
ALC : 78.99 (-1.30%)
Broadwood Partners Condemns Decision by STAAR Surgical and Alcon to Delay Final Vote on Proposed Transaction

Appalled that STAAR’s Board Reneged on Its Promise to Let Shareholders Decide the Fate of the Proposed Transaction in a Timely Manner Urges STAAR to...

STAA : 26.60 (+0.87%)
ALC : 78.99 (-1.30%)
Alcon and STAAR Surgical Announce Adjournment of STAAR Special Meeting of Stockholders

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, and STAAR Surgical Company (NASDAQ: STAA), the manufacturer of the Implantable Collamer® Lens (ICL), today...

STAA : 26.60 (+0.87%)
ALC : 78.99 (-1.30%)
Broadwood Partners Highlights Growing Opposition to STAAR Surgical’s Proposed Sale to Alcon

Leading Proxy Advisory Firms ISS, Glass Lewis, and Egan-Jones, as well as Long-Term Shareholders Echo Broadwood’s Concerns over Deeply Deficient Sale Process, Timing, and Price ...

STAA : 26.60 (+0.87%)
ALC : 78.99 (-1.30%)
Broadwood Partners Issues Letter to STAAR Surgical’s Board Urging it to Allow Timely Shareholder Vote on Alcon Sale

Calls on Board to Avoid Temptation to Delay Meeting or Further Mislead Shareholders Broadwood Continues to Urge Shareholders to Vote “ ...

STAA : 26.60 (+0.87%)
ALC : 78.99 (-1.30%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Alcon Inc. researches, develops, manufactures, distributes, and sells a full suite of eye care products. Alcon operates within two segments, Surgical and Vision Care. The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma...

See More

Key Turning Points

3rd Resistance Point 80.86
2nd Resistance Point 80.40
1st Resistance Point 79.69
Last Price 78.99
1st Support Level 78.52
2nd Support Level 78.06
3rd Support Level 77.35

See More

52-Week High 99.20
Fibonacci 61.8% 88.64
Fibonacci 50% 85.38
Fibonacci 38.2% 82.11
Last Price 78.99
52-Week Low 71.55

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar